ArticleJCI insight2017

VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.

Aaron Prodeus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.